Teva and Glenmark to Pay Over $250 Million to Settle Price-Fixing Charges

Teva will pay a $225 million fine over 5 years and donate $50 million in drugs to charities.
Glenmark will pay a $30 million fine for its role in the conspiracy.
The charges relate to fixing prices of the cholesterol drug pravastatin.
Teva and Glenmark admitted guilt and agreed to deferred prosecution deals.
With Teva and Glenmark, total fines now exceed $680 million across 7 drug companies.